Get the Stockscreener App
0.3491
13.46%
0.0441
Xtant Medical Holdings Inc stock is traded at $0.3491, with a volume of 1.59M.
It is up +13.46% in the last 24 hours and down -23.10% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.305
Open:
$0.31
24h Volume:
1.59M
Relative Volume:
10.63
Market Cap:
$48.97M
Revenue:
$121.91M
Net Income/Loss:
$1.83M
P/E Ratio:
32.03
EPS:
0.0109
Net Cash Flow:
$7.75M
1W Performance:
-22.41%
1M Performance:
-23.10%
6M Performance:
-41.40%
1Y Performance:
-45.22%
1-Day Range:
$0.31
$0.433
1-Week Range:
$0.2702
$0.433
52-Week Range:
$0.2702
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.3491 | 42.79M | 121.91M | 1.83M | 7.75M | 0.0109 |
ABT
Abbott Laboratories
|
110.11 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.33 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.67 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.55 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.83 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
Xtant Medical (XTNT) revenue drops 35% and turns to loss on divestitures, Dilon charge - Stock Titan
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract - TradingKey
Xtant Medical Q2 Revenue Falls To $23.0 Million - Quiver Quantitative
XTNT: Q2 2026 saw revenue drop, margin compression, and a net loss, prompting lower full-year guidance - TradingView
Xtant Medical Holdings, Inc. Lowers Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Xtant Medical Stockholders Approve Governance and Leadership Items - TipRanks
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026 - Morningstar
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Nasdaq
Three Xtant Medical executives join Aug. 11 conference webcast - Stock Titan
Xtant Medical (XTNT) Expected to Release Quarterly Earnings on Monday - MarketBeat
Xtant Medical Holdings Inc (XTNT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.003 - TradingKey
TradingKey - TradingKey
Xtant Medical Holdings Inc (XTNT) Cash Flow - TradingKey
Xtant Medical Holdings Inc (XTNT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.001 - TradingKey
Xtant Medical Holdings Inc (XTNT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xtant Medical (XTNT) Consolidates Near $0.43 with Minimal MovementHigh Volume Stocks - dars.gov.et
Xtant Medical Holdings Inc. (XTNT) Q1 2026 Earnings: EPS Misses Estimates as Strategic Progress ContinuesReturn On Assets - dars.gov.et
XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainAnalyst Consensus Shift - po-news-eg.net
XTNT stock trades around recent lows as Xtant Medical revenue climbs and losses narrow - Ad-hoc-news.de
SemiLEDs And 2 Other Promising Penny Stocks To Watch - simplywall.st
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Significant Growth in Short Interest - MarketBeat
Xtant Medical Holdings (XTNT) Holds Steady at $0.42 as Traders Eye Key LevelsHigh Beta Stocks - dars.gov.et
XTNT Q1 2026 Earnings: Narrow EPS Miss Amidst Measured Operational ProgressRevenue Surprise History - dars.gov.et
XTNT Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains Unreported Amid Stock DeclineEarnings Season Outlook - dars.gov.et
XTNT stock reflects niche spine focus as regenerative implants underpin the business - Ad-hoc-news.de
Xtant Medical Q1 2026 Earnings: EPS Misses Estimates Despite Positive Market ReactionNew Analyst Coverage - dars.gov.et
Xtant Medical Holdings outlines spine surgery focus as investors watch growth path - Ad Hoc News
XTNT Q1 2026 Earnings: EPS Misses Estimates as Loss WidensEarnings Volatility Report - dars.gov.et
Xtant Medical Holdings (XTNT) Pressures Support at $0.39 After 1.67% DeclineTrend Continuation Trade - dars.gov.et
Xtant Medical Holdings Inc (XTNT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XTNT, Friday review points to sector peers and shares - AD HOC NEWS
Enterprise value to EBITDA forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
Enterprise value to EBIT forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
XTNT Q1 2026 Earnings: EPS Misses Estimates, Revenue Not DisclosedLow Estimate Range - DonanımHaber
XTNT Forecast — Price Target — Prediction for 2027 - TradingView
Xtant Medical Holdings, Inc. Actuals & Estimates (AMEX:XTNT) - TradingView
Price to sales forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
Xtant Medical (NASDAQ: XTNT) details 2026 annual meeting, director slate and pay - Stock Titan
[ARS] Xtant Medical Holdings, Inc. SEC Filing - Stock Titan
Xtant Medical Holdings StockBackground and strategy snapshot - AD HOC NEWS
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):